{
    "code": "52026304",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=52026304",
    "time": "2021-06-25 03:16:02",
    "許可證字號": "衛部藥輸字第026304號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "113\/04\/28",
    "發證日期": "103\/04\/28",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA05202630409",
    "中文品名": "癌立佳持續性藥效皮下注射劑7.5毫克",
    "英文品名": "Eligard 7.5 mg, powder and solvent for solution for injection",
    "適應症": "用於晚期前列腺癌紓解治療，以及與放射治療併用於高風險的局部和局部晚期荷爾蒙依賴型前列腺癌治療。",
    "劑型": "243凍晶注射劑",
    "包裝": "每組含2支(A溶劑+B藥品)預充填式注射針筒及1支20號無菌注射針頭，紙盒裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "05限由醫師使用",
    "管制藥品分類級別": "",
    "藥品分類": "",
    "監視期限": "",
    "主成分略述": "LEUPRORELIN ACETATE",
    "限制項目": "02輸　入",
    "申請商名稱": "620110R660  台灣安斯泰來製藥股份有限公司",
    "申請商地址": "台北市中山區民生東路３段１０號５樓",
    "主製造廠": [
        {
            "製造廠名稱": "FUS9243000  TOLMAR INC.",
            "製造廠廠址": "701 CENTRE AVENUE, FORT COLLINS, CO 80526, USA",
            "製造廠公司地址": "",
            "製造廠國別": "UNITED STATES",
            "製程": ""
        }
    ],
    "次製造廠": [
        {
            "製造廠名稱": "FCH0232000  BACHEM AG",
            "製造廠廠址": "HAUPTSTRASSE 144 CH-4416 BUBENDORF, SWITZERLAND",
            "製造廠公司地址": "",
            "製造廠國別": "SWITZERLAND",
            "製程": "原料藥製造廠"
        },
        {
            "製造廠名稱": "FNL0047000  ASTELLAS PHARMA EUROPE B.V.",
            "製造廠廠址": "HOGEMAAT 2, 7942 JG MEPPEL, THE NETHERLANDS",
            "製造廠公司地址": "",
            "製造廠國別": "NETHERLANDS",
            "製程": "包裝"
        },
        {
            "製造廠名稱": "FUS0855000  ISOMEDIX OPERATIONS, INC.",
            "製造廠廠址": "9, APOLLO DRIVE WHIPPANY, NJ07981 USA",
            "製造廠公司地址": "",
            "製造廠國別": "UNITED STATES",
            "製程": "滅菌廠"
        },
        {
            "製造廠名稱": "FUS0856000  NELSON LABORATORIES",
            "製造廠廠址": "6280 S. REDWOOD ROAD SALT LAKE CITY, UT 84123 USA",
            "製造廠公司地址": "",
            "製造廠國別": "UNITED STATES",
            "製程": "檢驗廠"
        }
    ],
    "CCC號列": "30049071005 抗癌藥Anti-cancer preparations",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "6818000810",
            "成分名稱": "LEUPRORELIN ACETATE",
            "含量描述": "(Each Syringe B contains 10.6MG of Leuprorelin Acetate)",
            "含量": "7.5000000000",
            "單位": "MG"
        }
    ],
    "藥物辨識詳細資料": {
        "外觀尺寸": "",
        "特殊劑型": "",
        "顏色": "",
        "特殊氣味": "",
        "刻痕": "",
        "形狀": "",
        "標記一": "",
        "標記二": ""
    },
    "藥物辨識外觀圖片": [
        {
            "title": "ELG 7.5mg AB劑背面 -104-09-30(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52026304&Seq=002&Type=10"
        }
    ],
    "仿單外盒": [
        {
            "title": "ELG-I1812-06-108-06-19.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52026304&Seq=007&Type=9"
        },
        {
            "title": "Eligard_外盒_7.5mg-107-03-26(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52026304&Seq=005&Type=8"
        }
    ]
}